Paper32429338
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
Saeed M and 5 others. Cancers (Basel), 2020. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope. Papers, record 32429338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32429338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 2 | 19088187 | Genome-wide analysis of cancer/testis gene expression. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/19088187 | PubMed |
| 3 | 21130497 | Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability. | Mol Immunol | 2011 | https://conductscience.org/library/papers/21130497 | PubMed |
| 4 | 15751033 | NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. | Int J Cancer | 2005 | https://conductscience.org/library/papers/15751033 | PubMed |
| 5 | 23680437 | Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma. | J Transl Med | 2013 | https://conductscience.org/library/papers/23680437 | PubMed |
| 6 | 28187291 | The Principles of Engineering Immune Cells to Treat Cancer. | Cell | 2017 | https://conductscience.org/library/papers/28187291 | PubMed |
| 7 | 22936035 | Improving T cell responses to modified peptides in tumor vaccines. | Immunol Res | 2013 | https://conductscience.org/library/papers/22936035 | PubMed |
| 8 | 28025979 | Driving gene-engineered T cell immunotherapy of cancer. | Cell Res | 2017 | https://conductscience.org/library/papers/28025979 | PubMed |
| 9 | 22053972 | TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. | Int Rev Immunol | 2011 | https://conductscience.org/library/papers/22053972 | PubMed |
| 10 | 17637721 | Monoclonal T-cell receptors: new reagents for cancer therapy. | Mol Ther | 2007 | https://conductscience.org/library/papers/17637721 | PubMed |
| 11 | 20889925 | Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells. | Blood | 2011 | https://conductscience.org/library/papers/20889925 | PubMed |
| 12 | 8642276 | Human tumor antigens recognized by T lymphocytes. | J Exp Med | 1996 | https://conductscience.org/library/papers/8642276 | PubMed |
| 13 | 20525992 | Improved survival with ipilimumab in patients with metastatic melanoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20525992 | PubMed |
| 14 | 22907354 | Phage display and selections on cells. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22907354 | PubMed |
| 15 | 18446790 | Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. | Eur J Immunol | 2008 | https://conductscience.org/library/papers/18446790 | PubMed |
| 16 | 18676861 | Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. | Cancer Res | 2008 | https://conductscience.org/library/papers/18676861 | PubMed |
| 17 | 10981663 | Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. | Gene Ther | 2000 | https://conductscience.org/library/papers/10981663 | PubMed |
| 18 | 12370373 | Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies. | J Immunol | 2002 | https://conductscience.org/library/papers/12370373 | PubMed |
| 19 | 20639478 | Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. | J Immunol | 2010 | https://conductscience.org/library/papers/20639478 | PubMed |
| 20 | 15814707 | Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. | J Immunol | 2005 | https://conductscience.org/library/papers/15814707 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38803176 | The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets. | Curr Mol Med | 2025 | https://conductscience.org/library/papers/38803176 | PubMed |
| 36297598 | Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36297598 | PubMed |
| 33989511 | The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/33989511 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32429338
GET https://conductscience.org/api/papers/v1/32429338/references?page=2